Please login to the form below

Not currently logged in

Former Sanofi chairman joins Pertinax Pharma

Nigel Brooksby will drive the commercialisation of the company as chairman

Pertinax Pharma has appointed Nigel Brooksby as its new chairman, a role that will see him help drive the commercialisation of the company by assisting in corporate strategic and business developments.

During his 38-year career in the pharmaceutical industry, Brooksby has served in roles such from medical sales representative to chairman.

He has held senior appointments in Wellcome - now GSK, Pfizer and as chairman and MD at Sanofi UK and Ireland and as a member of the Sanofi Executive Committee in Europe and America.

Michele Barbour, founder and chief scientific officer, Pertinax Pharma, said: “We are delighted that Nigel has chosen to join our board.

“His unparalleled experience in the pharmaceutical and related industries, his long established industry connections and his experience with early stage biomedical companies make him the ideal individual for the tasks at hand.

“We look forward to Nigel playing a pivotal role in Pertinax Pharma’s continued development as bring the benefits of our patented and commercialised Pertinax technology to the healthcare sector.”

24th November 2017

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
3 Monkeys Zeno

3 Monkeys Zeno is the UK arm of Zeno Group, a global integrated communications consultancy. Everything we do is rooted...

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....